Appendix Table 1.
Racial/Ethnic Difference in 6-Month Among Those Who Survived ≥ 6-Month and 1-Year Medication Adherence Among Those Who Survived ≥ 1-Year*
| Part (1) Angiotensin-converting enzyme inhibitor/Angiotensin II receptor blockers | ||||||||
|---|---|---|---|---|---|---|---|---|
| Panel A. Disabled | ||||||||
| 6-Month Adherence | 1-year Adherence | |||||||
| Race | Unadjusted | Fully Adjusted† | Unadjusted | Fully Adjusted† | ||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Black | 0.65 | (0.59, 0.72) | 0.82 | (0.73, 0.92) | 0.63 | (0.56, 0.70) | 0.80 | (0.70, 0.90) |
| Native | 0.92 | (0.59, 1.44) | 0.90 | (0.56, 1.44) | 0.80 | (0.52, 1.23) | 0.76 | (0.48, 1.22) |
| Hispanic | 0.79 | (0.68, 0.92) | 0.89 | (0.75, 1.06) | 0.80 | (0.69, 0.94) | 0.86 | (0.72, 1.04) |
| Asian | 0.75 | (0.54, 1.06) | 0.91 | (0.63, 1.33) | 0.86 | (0.60, 1.22) | 0.92 | (0.62, 1.35) |
| White | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference |
| Panel B. Aged | ||||||||
| 6-Month Adherence | 1-year Adherence | |||||||
| Race | Unadjusted | Fully Adjusted† | Unadjusted | Fully Adjusted† | ||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Black | 0.76 | (0.71, 0.81) | 0.82 | (0.76, 0.89) | 0.77 | (0.71, 0.82) | 0.81 | (0.75, 0.87) |
| Native | 0.73 | (0.58, 0.93) | 0.76 | (0.59, 0.97) | 0.71 | (0.56, 0.91) | 0.75 | (0.58, 0.97) |
| Hispanic | 0.95 | (0.88, 1.03) | 0.97 | (0.88, 1.06) | 0.90 | (0.83, 0.97) | 0.91 | (0.83, 0.99) |
| Asian | 0.97 | (0.86, 1.10) | 0.87 | (0.76, 0.99) | 0.97 | (0.85, 1.10) | 0.86 | (0.75, 0.98) |
| White | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference |
| Part (2) Statin | ||||||||
| Panel A. Disabled | ||||||||
| 6-Month Adherence | 1-year Adherence | |||||||
| Race | Unadjusted | Fully Adjusted† | Unadjusted | Fully Adjusted† | ||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Black | 0.53 | (0.48, 0.59) | 0.63 | (0.56, 0.71) | 0.49 | (0.44, 0.54) | 0.59 | (0.52, 0.67) |
| Native | 0.66 | (0.44, 0.97) | 0.65 | (0.43, 1.00) | 0.53 | (0.36, 0.79) | 0.52 | (0.34, 0.79) |
| Hispanic | 0.69 | (0.60, 0.79) | 0.74 | (0.63, 0.87) | 0.69 | (0.59, 0.79) | 0.76 | (0.64, 0.90) |
| Asian | 0.74 | (0.53, 1.02) | 0.69 | (0.48, 0.99) | 0.91 | (0.65, 1.27) | 0.92 | (0.63, 1.35) |
| White | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference |
| Panel B. Aged | ||||||||
| 6-Month Adherence | 1-year Adherence | |||||||
| Race | Unadjusted | Fully Adjusted† | Unadjusted | Fully Adjusted† | ||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Black | 0.62 | (0.58, 0.66) | 0.69 | (0.65, 0.75) | 0.62 | (0.58, 0.66) | 0.67 | (0.62, 0.73) |
| Native | 0.65 | (0.52, 0.82) | 0.70 | (0.55, 0.89) | 0.61 | (0.48, 0.77) | 0.65 | (0.51, 0.84) |
| Hispanic | 0.76 | (0.70, 0.82) | 0.80 | (0.74, 0.88) | 0.76 | (0.71, 0.82) | 0.79 | (0.73, 0.87) |
| Asian | 1.03 | (0.91, 1.16) | 0.91 | (0.80, 1.04) | 1.08 | (0.95, 1.21) | 0.95 | (0.83, 1.08) |
| White | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference | 1.00 | Reference |
*
Bold denote statistically significant at p-value <0.05.
†
“Fully Adjusted” means adjusted for all covariates discussed in the Statistical Analysis section.